Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Veracyte, Inc.

< Previous 1 2 3 4 5 Next >
Veracyte Announces New Urologic Cancer Data To Be Presented at AUA 2022 International Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Performance Data for the Percepta Nasal Swab Test To Be Presented at ATS 2022 International Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Release First Quarter 2022 Financial Results on May 3, 2022
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Appoints Annie McGuire as General Counsel
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Appoints Jonathan Wygant as Chief Accounting Officer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Release Fourth Quarter and Full-Year 2021 Financial Results on February 28, 2022
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier To Help Guide Therapy In Men with Intermediate-Risk Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Participate in 11th Annual SVB Leerink Global Healthcare Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data Suggest Veracyte’s Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces Key Leadership Promotions to Advance Its Strategic Global Vision
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer Test
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Data on Immuno-Oncology Offerings Presented at SITC 2021
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces Third Quarter 2021 Financial Results
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company’s Immuno-Oncology Capabilities
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data Demonstrate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After Surgery
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Publication Demonstrates Ability of Veracyte’s Decipher Bladder Test to Identify Tumors Most Likely to Respond to Chemotherapy
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte’s Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical Prostatectomy
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte to Participate in Morgan Stanley 19th Annual Global Healthcare Conference
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
Veracyte Named a San Francisco Bay Area “Top Workplace” for Eighth Consecutive Year
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback